Literature DB >> 18945878

Evaluation of antigen-specific T-cell responses with a miniaturized and automated method.

Giuseppina Li Pira1, Federico Ivaldi, Chiara Dentone, Elda Righi, Valerio Del Bono, Claudio Viscoli, Gerrit Koopman, Fabrizio Manca.   

Abstract

The evaluation of antigen-specific T-cell responses is helpful for both research and clinical settings. Several techniques can enumerate antigen-responsive T cells or measure their products, but they require remarkable amounts of peripheral blood mononuclear cells (PBMCs). Since screening numerous antigens or testing samples from pediatric or lymphopenic patients is hampered in clinical practice, we refined a miniaturized, high-throughput assay for T-cell immunity. Antigens and cells in 10-microl volumes were dispensed into 1,536-well culture plates precoated with anti-gamma interferon (anti-IFN-gamma) antibodies. After being cultured, the wells were developed by enzyme-linked immunosorbent assay for bound cytokine. Miniaturization and automation allowed quantitation of antigen-specific responses on 10(4) PBMCs. This method was applied for epitope mapping of mycobacterial antigens and was used in the clinic to evaluate T-cell immunity to relevant opportunistic pathogens by using small blood samples. A comparison with conventional methods showed similar sensitivity. Therefore, current flow cytometric methods that provide information on frequency and phenotype of specific T cells can be complemented by this assay that provides extensive information on cytokine concentrations and profiles and requires 20- to 50-fold fewer PBMCs than other analytical methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945878      PMCID: PMC2593160          DOI: 10.1128/CVI.00322-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  20 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals.

Authors:  Florian Kern; Torsten Bunde; Nicole Faulhaber; Felix Kiecker; Elham Khatamzas; Ina-Maria Rudawski; Axel Pruss; Jan-Willem Gratama; Rudolf Volkmer-Engert; Ralf Ewert; Petra Reinke; Hans-Dieter Volk; Louis J Picker
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

Review 3.  Antigen-specific cytometry--new tools arrived!

Authors:  Andreas Thiel; Alexander Scheffold; Andreas Radbruch
Journal:  Clin Immunol       Date:  2004-05       Impact factor: 3.969

4.  Helper function of cytolytic lymphocytes: switching roles in the immune response.

Authors:  Giuseppina Li Pira; Federico Ivaldi; Laura Bottone; Gerrit Koopman; Fabrizio Manca
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

Review 5.  Immune epitope mapping in the post-genomic era: lessons for vaccine development.

Authors:  Alessandro Sette; Bjoern Peters
Journal:  Curr Opin Immunol       Date:  2006-11-17       Impact factor: 7.486

6.  Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis.

Authors:  Eliane M S Leyten; May Young Lin; Kees L M C Franken; Annemieke H Friggen; Corine Prins; Krista E van Meijgaarden; Martin I Voskuil; Karin Weldingh; Peter Andersen; Gary K Schoolnik; Sandra M Arend; Tom H M Ottenhoff; Michèl R Klein
Journal:  Microbes Infect       Date:  2006-06-13       Impact factor: 2.700

7.  Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity, by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire.

Authors:  Giuseppina Li Pira; Laura Bottone; Federico Ivaldi; Augusto Tagliamacco; Stefano Fiordoro; Annamaria Ricciardi; Giancarlo Barbano; Fabrizio Manca
Journal:  J Infect Dis       Date:  2004-12-14       Impact factor: 5.226

8.  Optimizing peptide matrices for identifying T-cell antigens.

Authors:  Melissa L Precopio; Tiffany R Butterfield; Joseph P Casazza; Susan J Little; Douglas D Richman; Richard A Koup; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

9.  The curation guidelines of the immune epitope database and analysis resource.

Authors:  R Vita; B Peters; A Sette
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

10.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

View more
  4 in total

1.  Miniaturized and high-throughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV.

Authors:  Giuseppina Li Pira; Federico Ivaldi; Nadia Starc; Fabiola Landi; Franco Locatelli; Sergio Rutella; Gino Tripodi; Fabrizio Manca
Journal:  Clin Vaccine Immunol       Date:  2014-01-29

Review 2.  High throughput T epitope mapping and vaccine development.

Authors:  Giuseppina Li Pira; Federico Ivaldi; Paolo Moretti; Fabrizio Manca
Journal:  J Biomed Biotechnol       Date:  2010-06-15

3.  The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.

Authors:  Bianca R Mothé; Cecilia S Lindestam Arlehamn; Courtney Dow; Myles B C Dillon; Roger W Wiseman; Patrick Bohn; Julie Karl; Nadia A Golden; Trey Gilpin; Taylor W Foreman; Mark A Rodgers; Smriti Mehra; Thomas J Scriba; JoAnne L Flynn; Deepak Kaushal; David H O'Connor; Alessandro Sette
Journal:  Tuberculosis (Edinb)       Date:  2015-08-28       Impact factor: 3.131

4.  Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA.

Authors:  Diana Campillo-Davo; Maarten Versteven; Gils Roex; Hans De Reu; Sanne van der Heijden; Sébastien Anguille; Zwi N Berneman; Viggo F I Van Tendeloo; Eva Lion
Journal:  Cancers (Basel)       Date:  2020-01-21       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.